Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.
About BioLargo, Inc. (OTCQB: BLGO)
BioLargo, Inc. is a pioneering cleantech and life sciences company committed to addressing some of the world’s most pressing environmental and health challenges. Through its innovative technologies and engineering solutions, BioLargo focuses on delivering sustainable and cost-effective products that improve water quality, air quality, energy efficiency, and healthcare outcomes. The company’s mission is to make life better by solving tough environmental and cleantech challenges while contributing to a sustainable future.
Core Business Areas
BioLargo operates across several critical sectors, leveraging its expertise to provide transformative solutions:
- Water Treatment: BioLargo’s Advanced Oxidation System (AOS) is a breakthrough water treatment technology designed to eliminate toxic contaminants, including PFAS, efficiently and cost-effectively. This system has been recognized as a leader in the water treatment market.
- Energy Storage: The company’s Cellinity™ liquid sodium battery technology offers a safer, more sustainable, and cost-effective alternative to lithium-ion batteries, ideal for grid-scale energy storage and renewable energy applications.
- Air Quality and Odor Control: BioLargo provides innovative solutions for controlling odors and volatile organic compounds (VOCs), serving industries such as waste management and agriculture.
- Medical Technologies: Through its subsidiary Clyra Medical Technologies, BioLargo develops advanced healthcare solutions, including the FDA-cleared Bioclynse surgical wound irrigation solution, which improves patient outcomes in medical and dental applications.
- Engineering Services: BioLargo’s engineering subsidiary offers environmental compliance services, including air quality management, for clients such as the U.S. Air Force.
Business Model and Strategy
BioLargo’s business model revolves around inventing or acquiring innovative technologies, validating their efficacy, and commercializing them through licensing agreements and strategic partnerships. This approach enables the company to scale its operations efficiently while preserving capital and human resources. By focusing on intellectual property and forming alliances with industry leaders, BioLargo maximizes the market impact of its solutions.
Competitive Differentiation
BioLargo stands out in the cleantech and life sciences industries due to its diversified portfolio of patented technologies and its commitment to sustainability. The company’s solutions address critical issues like PFAS contamination, renewable energy storage, and surgical infection control, offering unique advantages in performance, cost-efficiency, and environmental impact. Industry recognition, such as Frost & Sullivan’s Technology Innovation Leader award, underscores BioLargo’s position as a market innovator.
Market Impact and Future Potential
With a growing portfolio of commercialized products and long-term contracts, BioLargo is well-positioned to capitalize on the increasing demand for sustainable technologies. The company’s ability to secure recurring revenue streams, such as its contracts with the U.S. Air Force, and its focus on addressing global challenges like water scarcity and energy transition, highlight its potential for long-term growth and impact.
Conclusion
BioLargo, Inc. is a forward-thinking company at the intersection of cleantech and life sciences. Its commitment to innovation, sustainability, and strategic partnerships positions it as a key player in addressing some of the most critical challenges of our time. By leveraging its expertise and diversified portfolio, BioLargo continues to drive meaningful change in industries ranging from water treatment to energy storage and healthcare.
BioLargo, Inc. (OTCQB:BLGO) will hold its annual stockholder meeting on June 15, 2021, at 10:00 am PT via live webcast due to COVID-19 considerations. Stockholders can register online and are encouraged to vote, with eligibility based on ownership as of April 19, 2021. The meeting will feature discussions on recent annual and quarterly financial results, followed by a Q&A session. BioLargo focuses on sustainable clean technologies and environmental engineering, holding extensive patents and a variety of innovative products aimed at addressing environmental challenges.
BioLargo, Inc. (OTCQB:BLGO) will present at the LD Micro virtual event on June 9, 2021, at 5:00 PM ET. CEO Dennis P. Calvert will discuss innovative sustainable water treatment technologies, particularly targeting PFAS contamination, which poses significant health risks globally. This technology is positioned as an affordable and eco-friendly solution. The LD Micro Invitational XI will run from June 8-10, 2021, featuring around 180 companies. Interested parties can register to view the presentation here.
BioLargo (OTCQB:BLGO) announced the elimination of nearly all convertible debt, having paid off $406,000 due in August 2021. This reduction leaves only $464,000 in SBA and PPP loans and $50,000 in fixed-price convertible debt on the balance sheet. CEO Dennis Calvert noted the debt reduction from $7.6 million three years ago and highlighted a financing commitment of over $6 million. The company's environmental technologies, including the Advanced Oxidation System (AOS), are ready for commercial launch, supporting revenue growth and new partnerships.
BioLargo, Inc. (OTCQB:BLGO) filed its Q1 2021 report, highlighting a 30% revenue increase to $571,000 compared to the previous year. The company's net loss decreased by 28% thanks to a significant reduction in interest expenses. BioLargo has retired $650,000 in debt this year, improving its financial position ahead of plans to uplist to a national exchange. CEO Dennis Calvert emphasized the commercial potential of their PFAS remediation technology in a growing $80 billion market. Upcoming commercial pilots for this technology are set to start soon.
BioLargo, Inc. (OTCQB:BLGO) will host an investor webcast and conference call on May 19, 2021, at 1:30 PM PT / 4:30 PM ET. The session aims to discuss the company's financial results and recent developments. The event is open to the public, with access to a replay available for later viewing. BioLargo specializes in developing sustainable technologies for environmental challenges, holding numerous patents, and operating through various subsidiaries. The webcast details and participation links are provided in the company’s investor relations section.
BioLargo, Inc. (OTCQB:BLGO) will present at the Benzinga Global Small Cap Conference on May 14, 2021, at 10:10 a.m. ET. The conference aims to connect small-cap companies with investors, focusing on cleantech advancements and growth prospects. CEO Dennis P. Calvert emphasizes BioLargo's dynamic business model, notably in PFAS remediation and water treatment. The event is free to attend, providing valuable insights into the company's innovative solutions. For registration, visit here.
BioLargo, Inc. (OTCQB:BLGO) has achieved a significant technical milestone with its Aqueous Electrostatic Concentrator (AEC), designed for treating PFAS-contaminated water. This development improves the AEC's electrical configuration, significantly reducing operating and maintenance costs. As a result, BioLargo can now finalize agreements for demonstration pilots and commercial trials. The AEC offers advantages over traditional PFAS filtration methods, with lower waste generation and reduced costs. The company is also enhancing its intellectual property related to the technology.
BioLargo, Inc. (OTCQB:BLGO) will present at the Benzinga Cleantech Small Cap Conference on April 22, 2021, at 11:20 AM EST. The company specializes in sustainable technologies and environmental engineering. CEO Dennis P. Calvert emphasized BioLargo's advancements in water remediation technologies, aimed at addressing critical global challenges. The conference focuses on clean technologies that promote eco-friendly practices.
Interested parties can sign up for the conference here.
BioLargo, Inc. (OTCQB:BLGO) filed its 2020 Annual Report with significant highlights. Revenue reached $2.43 million, a 31% increase from 2019, with fourth-quarter revenue of $900,000, up 36% from the previous quarter. The company reduced debt from $4.8 million to $1.7 million and announced the upcoming commercial launch of its PFAS water treatment solution. BioLargo continues to enhance its strategic partnerships and expand its technology offerings, positioning for future growth despite challenges from the COVID-19 pandemic.
BioLargo, Inc. (OTCQB:BLGO) announces a webcast and conference call on March 31, 2021, at 2 PM PST to discuss its 2020 financial results, releasing them after market close on March 30, 2021. The event will include a Q&A session open to the public. Interested participants can access the webcast on the company's Investor Relations page. BioLargo focuses on innovative environmental solutions and has secured over 80 grants to support its initiatives.
FAQ
What is the current stock price of Biolargo (BLGO)?
What is the market cap of Biolargo (BLGO)?
What does BioLargo, Inc. do?
How does BioLargo generate revenue?
What is BioLargo's Advanced Oxidation System (AOS)?
What makes BioLargo's Cellinity battery unique?
What industries does BioLargo serve?
What is Clyra Medical Technologies?
How does BioLargo address PFAS contamination?
What are BioLargo's competitive advantages?
What is BioLargo's approach to commercialization?
What recognition has BioLargo received for its innovations?
